Cross-Sectional Comparison of Sleep-Disordered Breathing in Native Peruvian Highlanders and Lowlanders.

Pham, V. Luu, Christopher Meinzen, Rafael S. Arias, Noah G. Schwartz, Adi Rattner, Catherine H. Miele, Philip L. Smith, Hartmut Schneider, J. Jaime Miranda, Robert H. Gilman, Vsevolod Y. Polotsky, William Checkley, and Alan R. Schwartz. comparative cross-sectional study of sleep-disordered breathing in the original Peruvian highlands and lowlands. High Alt Med Biol. 18: 11-19, 2017.


BACKGROUND
Altitude can highlight irregular sleep breathing (SDB), which has been associated with cardiovascular and metabolic diseases. SDB on the plateau is not marked in large controlled studies. The purpose of this study was to compare the prevalence and severity of SDB in the highlands and lowlands.


METHOD
170 age, body-mass Index, (BMI), and gender couples (age 58.2 ± 12.4 years, BMI 27.2 ± 3.5 kg / m2, and 86 male and 84 female) from Crónicas Cohort Study recruited at sea level (Lima) and high altitude (Puno, 3825 m) arrangements in Peru. Participants underwent nocturnal polygraph simultaneously and actigraphy to characterize patterns of breathing, movement arousals, and sleep / wake state. We compared the prevalence of SDB, type, and severity between the highlands and lowlands as measured by the apnea-hypopnea index (AHI) and pulse oximetry (SpO2) during sleep.


RESULTS
Greater prevalence of sleep apnea in the highlands than in the lowlands (77% vs 54%, p <0.001). Compared with the lowlands, highlands have a two-fold increase in AHI due to the increase in the central rather than obstructive apnea. On the plateau compared with the lowlands, lower SpO2 during wakefulness and a further decrease during sleep (p <0.001). Hypoxemia during wakefulness predict sleep apnea in the highlands, and it seems to mediate the effects of altitude on the prevalence of sleep apnea. Surprisingly, hypoxemia also quite common in the lowlands, and it is also associated with an increased likelihood of sleep apnea.


CONCLUSION
high altitude and hypoxemia at both high and low altitudes associated with an increased prevalence and severity of SDB. Our findings show that most of the highlands remain at risk for SDB sequelae.

 Cross-Sectional Comparison of Sleep-Disordered Breathing in Native Peruvian Highlanders and Lowlanders.
Cross-Sectional Comparison of Sleep-Disordered Breathing in Native Peruvian Highlanders and Lowlanders.

Increased Cardiometabolic Risk and Worsening hypoxemia at High Altitude.

Miele, Catherine H., Alan R. Schwartz, Robert H. Gilman, Luu Pham, Robert A. Wise, Victor G. Davila-Roman, Jonathan C. June, Vsevolod Y. Polotsky, J. Jaime Miranda, Fabiola Leon-Velarde and William Checkley. Increased risk of cardiometabolic and worsening hypoxemia at high altitude. High Alt Med Biol. 17: 93-100 syndrome, 2016.-Metabolic, insulin resistance, diabetes, and dyslipidemia associated with an increased risk of cardiovascular disease.

While excessive erythrocytosis is associated with cardiovascular complications, it is not clear how the worsening hypoxemia of any level affecting cardiometabolic risk factors in a population of high altitude. We studied the relationship between lunch break oxyhemoglobin saturation and cardiometabolic risk factors in adult participants who stay in Puno, Peru (3825 m asl). We used multivariable logistic regression model to study the relationship between having a lower oxyhemoglobin saturation and cardiometabolic risk markers.

BMP-7

MO15079 500 ug
EUR 1092

BMP-7

PR27026-B each
EUR 184.5

BMP-7/ Rat BMP- 7 ELISA Kit

ELA-E0799r 96 Tests
EUR 1063.2

BMP-7 CHO

PR27001 2 ug
EUR 229.2

BMP-7, Human

E34M068H 5 μg
EUR 155

BMP-7, Human

HY-P7008 50ug
EUR 734.4

BMP-7 Antibody

E301185 100ug/200ul
EUR 275
Description: Available in various conjugation types.

BMP-7 Antibody

5677-100 each
EUR 430.8

BMP-7 Antibody

5677R-100 each
EUR 379.2

BMP-7 Antibody

5677R-30T each
EUR 175.2

BMP-7 Antibody

GWB-5B4980 1 ml Ask for price

BMP-7 Antibody

GWB-CF1347 0.05 mg Ask for price

BMP 7 antibody

20R-1847 100 ug
EUR 807.6
Description: Rabbit polyclonal BMP 7 antibody

BMP 7 antibody

20R-1848 100 ug
EUR 781.2
Description: Goat polyclonal BMP 7 antibody

Anti-Human BMP-7

GWB-BIG3BE 500ug Ask for price

Human BMP-7 Antibody

32701-05111 150 ug
EUR 215

BMP-7 Antibody (Biotin)

GWB-615F20 0.05 mg Ask for price

BMP-7, human recombinant

4579-10 each
EUR 307.2

BMP-7, human recombinant

4579-1000 each
EUR 5475.6

BMP-7, human recombinant

4579-50 each
EUR 738

Recombinant Human BMP-7

HEOPP-0210 10ug Ask for price

BMP-7 Polyclonal Antibody

ABP50780-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of BMP-7 from Human, Mouse, Rat. This BMP-7 antibody is for WB , IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human BMP-7

BMP-7 Polyclonal Antibody

ABP50780-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of BMP-7 from Human, Mouse, Rat. This BMP-7 antibody is for WB , IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human BMP-7

BMP-7 Polyclonal Antibody

ABP50780-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of BMP-7 from Human, Mouse, Rat. This BMP-7 antibody is for WB , IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human BMP-7

BMP-7 Polyclonal Antibody

40651 100ul
EUR 319

BMP-7 Polyclonal Antibody

40651-100ul 100ul
EUR 302.4

BMP-7 Polyclonal Antibody

40651-50ul 50ul
EUR 224.4

BMP-7 Recombinant Protein

40-641 2 ug
EUR 311.1
Description: TGF-β family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth, and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling, and maintenance of a variety of other tissues and organs. BMP-7, also known as osteogenic protein-1 or OP-1, is a potent bone inducing agent, which in the presence of an appropriate osteoconductive carrier (e.g. collagen sponge or synthetic hydroxyapatite) can be used in the treatment of bone defects. A bone-graft substitute, called OP-1TM implant, made of recombinant human BMP-7 associated with bovine bone-derived collagen, has recently been approved by the FDA as a device for treating critical-size bone fractures. The potential use of BMP-7 in dental reconstructive surgeries is currently under investigation. Recombinant Human BMP-7 is a 28.8 kDa homodimeric glycoprotein consisting of two 117 amino acid subunits, which correspond to amino acid residues 315 to 431 of the full-length BMP-7 precursor.

BMP-7 Recombinant Protein

40-642 2 ug
EUR 311.1
Description: TGF-β family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth, and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling, and maintenance of a variety of other tissues and organs. BMP-7, also known as osteogenic protein-1 or OP-1, is a potent bone inducing agent, which in the presence of an appropriate osteoconductive carrier (e.g. collagen sponge or synthetic hydroxyapatite) can be used in the treatment of bone defects. A bone-graft substitute, called OP-1TM implant, made of recombinant human BMP-7 associated with bovine bone-derived collagen, has recently been approved by the FDA as a device for treating critical-size bone fractures. The potential use of BMP-7 in dental reconstructive surgeries is currently under investigation. Recombinant Human BMP-7 is a homodimeric glycoprotein consisting of two 117 amino acid subunits, which correspond to amino acid residues 315 to 431 of the full-length BMP-7 precursor. Recombinant Human BMP-7 has a calculated molecular weight of 26.4 kDa; however, due to glycosylation, the BMP-7 homodimer migrates at an apparent molecular weight of approximately 25-35 kDa by SDS-PAGE analysis under non-reducing conditions.

BMP-7 Polyclonal Antibody

E040651 100μg/100μl
EUR 255
Description: Available in various conjugation types.

BMP-7 Polyclonal Antibody

E20-70503 100ug
EUR 225
Description: Available in various conjugation types.

BMP-7 Polyclonal Antibody

E44H01673 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

BMP-7 Polyclonal Antibody

E-AB-40594-100uL 100uL
EUR 230
Description: Unconjugated

BMP-7 Polyclonal Antibody

E-AB-40594-200uL 200uL
EUR 380
Description: Unconjugated

BMP-7 Polyclonal Antibody

E-AB-40594-20uL 20uL
EUR 65
Description: Unconjugated

BMP-7 Polyclonal Antibody

E-AB-40594-50uL 50uL
EUR 125
Description: Unconjugated

Rat BMP-7 ELISA Kit

EK5675 96 tests
EUR 599

Human BMP-7 ELISA Kit

E16HE0182 96T
EUR 1000

BMP-7 ELISA KIT|Human

EF000036 96 Tests
EUR 826.8

BMP-7 (Human) ELISA Kit

EKA52015-5x96T 5x96T Ask for price

BMP-7 (Human) ELISA Kit

EKA52015-96T 96T
EUR 446.9

Human BMP-7 ELISA KIT

E42EH-58 96T/48T Ask for price

Human BMP-7 ELISA Kit

E28L0440 96T
EUR 666.67

Human BMP-7 ELISA Kit

EK5396 96 tests
EUR 599

Mouse BMP-7 ELISA Kit

EK5674 96 tests
EUR 599

Human BMP-7 ELISA Kit

GWB-SKR199 96 Tests Ask for price

BMP-7 (human) ELISA Kit

K4749-100 100 assays
EUR 970.8
Description: Sensitive, Colorimetric Assay

Human BMP-7 ELISA Kit

LF-EK50940 1×96T
EUR 777.6

Rabbit Anti-Human BMP-7

102-PA92 100ug
EUR 240

Anti-Human BMP-7 Antibody

101-M149 100 µg
EUR 399
Description: Bone morphogenetic protein 7 (BMP7), also known as osteogenic protein 1 (OP1), is a widely expressed TGFβ superfamily member with important functions during embryogenesis, in the adult, and in disease. Human BMP7 is synthesized with a 29 amino acid (aa) signal sequence, a 263 aa propeptide, and a 139 aa growth factor domain. The growth factor domain of human BMP7 shares 98% aa sequence identity with mouse and rat BMP7. The BMP7 propeptide is cleaved intracellularly but often remains associated with the mature Cterminus. Based on in vivo and in vitro studies, BMP 7 has the potential to be secreted as a disulfidelinked mature homodimer, or particularly as a heteromeric complex that consists of two propeptides noncovalently associated with a mature disulfidelinked homodimer. The presence of the propeptides in BMP7 appears to stabilize the molecule and provide a docking mechanism for extracellular storage on molecules such as fibrillin 1 and 2 . The propeptides themselves do not impart latency to the complex. BMP7 binding to type II receptors rapidly displaces the prodomain:mature molecule interaction and has no effect on activity. But it is suggested that immobilized BMP7 (via prodomain:fibrillin) is inactive, allowing for possible longterm storage of the molecule. BMP 7 interacts with the type 2 receptors Activin RIIA, Activin RIIB, and BMPRII and the type 1 receptors Activin RIA, BMPRIA, and BMPRIB. BMP7 may also be processed into a disulfidelinked heterodimer with either BMP2 or BMP4. Such complexes may show increased potency and range of activity compared to BMP7 homodimers. BMP7 plays a role in a variety of organ systems. It promotes new bone formation and nephron development (10, 11), inhibits the branching of prostate epithelium (12), and antagonizes epithelialmesenchymal transition (EMT).

Anti-Human BMP-7 Antibody

101-M167 500 µg
EUR 244.65
Description: TGF-β family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling and maintenance of a variety of other tissues and organs. BMP-7, also known as osteogenic protein-1 or OP-1, is a potent bone inducing agent, which in the presence of appropriate osteoconductive carrier (e.g. collagen sponge or synthetic hydroxyapatite) can be used in the treatment of bone defects. A bone-graft substitute, called OP-1TM implant, made of recombinant human BMP-7 associated with bovine bone-derived collagen, has recently been approved by the FDA as a device for treating critical-size bone fractures. The potential use of BMP-7 in dental reconstructive surgeries is currently under investigation. Recombinant human BMP-7 is a 28.8 kDa homodimeric glycoprotein consisting of two 116 amino acid subunits, which correspond to amino acid residues 316 to 431 of the full-length BMP-7 precursor.

Anti-Human BMP-7 Antibody

101-M238 100 µg
EUR 399
Description: Bone morphogenetic protein 7 (BMP7), also known as osteogenic protein 1 (OP1), is a widely expressed TGFβ superfamily member with important functions during embryogenesis, in the adult, and in disease. Human BMP7 is synthesized with a 29 amino acid (aa) signal sequence, a 263 aa propeptide, and a 139 aa growth factor domain. The growth factor domain of human BMP7 shares 98% aa sequence identity with mouse and rat BMP7. The BMP7 propeptide is cleaved intracellularly but often remains associated with the mature Cterminus. Based on in vivo and in vitro studies, BMP 7 has the potential to be secreted as a disulfidelinked mature homodimer, or particularly as a heteromeric complex that consists of two propeptides noncovalently associated with a mature disulfidelinked homodimer. The presence of the propeptides in BMP7 appears to stabilize the molecule and provide a docking mechanism for extracellular storage on molecules such as fibrillin 1 and 2 . The propeptides themselves do not impart latency to the complex. BMP7 binding to type II receptors rapidly displaces the prodomain:mature molecule interaction and has no effect on activity. But it is suggested that immobilized BMP7 (via prodomain:fibrillin) is inactive, allowing for possible longterm storage of the molecule. BMP 7 interacts with the type 2 receptors Activin RIIA, Activin RIIB, and BMPRII and the type 1 receptors Activin RIA, BMPRIA, and BMPRIB. BMP7 may also be processed into a disulfidelinked heterodimer with either BMP2 or BMP4. Such complexes may show increased potency and range of activity compared to BMP7 homodimers. BMP7 plays a role in a variety of organ systems. It promotes new bone formation and nephron development (10, 11), inhibits the branching of prostate epithelium (12), and antagonizes epithelialmesenchymal transition (EMT).

Anti-Human BMP-7 Antibody

102-P105 100 µg
EUR 245.7
Description: TGF-β family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling and maintenance of a variety of other tissues and organs. BMP-7, also known as osteogenic protein-1 or OP-1, is a potent bone inducing agent, which in the presence of appropriate osteoconductive carrier (e.g. collagen sponge or synthetic hydroxyapatite) can be used in the treatment of bone defects. A bone-graft substitute, called OP-1TM implant, made of recombinant human BMP-7 associated with bovine bone-derived collagen, has recently been approved by the FDA as a device for treating critical-size bone fractures. The potential use of BMP-7 in dental reconstructive surgeries is currently under investigation. Recombinant human BMP-7 is a 28.8 kDa homodimeric glycoprotein consisting of two 116 amino acid subunits, which correspond to amino acid residues 316 to 431 of the full-length BMP-7 precursor.

Anti-Human BMP-7 Antibody

102-PA92S 100 µg
EUR 126
Description: Bone morphogenetic protein 7 (BMP-7), also known as osteogenic protein 1 (OP1), is a widely expressed TGFβ superfamily member with important functions during embryogenesis, in the adult, and in disease. Human BMP-7 is synthesized with a 29 amino acid (aa) signal sequence, a 263 aa propeptide, and a 139 aa growth factor domain. The growth factor domain of human BMP-7 shares 98% aa sequence identity with mouse and rat BMP-7. The BMP-7 propeptide is cleaved intracellularly but often remains associated with the mature C-terminus. Based on in vivo and in vitro studies, BMP-7 has the potential to be secreted as a disulfide-linked mature homodimer, or particularly as a heteromeric complex that consists of two propeptides noncovalently associated with a mature disulfide linked homodimer. The presence of the propeptides in BMP-7 appears to stabilize the molecule and provide a docking mechanism for extracellular storage on molecules such as fibrillin1 and 2. The propeptides themselves do not impart latency to the complex. BMP-7 binding to type II receptors rapidly displaces the prodomain: mature molecule interaction and has no effect on activity.BMP-7 plays a role in a variety of organ systems. It promotes new bone formation and nephron development, inhibits the branching of prostate epithelium, and antagonizes epithelial mesenchymal transition (EMT). In pathological conditions, BMP-7 inhibits tumor growth and metastasis, ameliorates fibrotic damage in nephritis, and promotes neuro regeneration following brain ischemia.

BMP-7 (E173) polyclonal antibody

E43S3674 100ul
EUR 225
Description: Available in various conjugation types.

OAPA00163-5UG - BMP-7 Antibody

OAPA00163-5UG 5ug
EUR 69

Human BMP-7 Recombinant Protein

100-328 10 µg
EUR 196.35
Description: TGF-β family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling and maintenance of a variety of other tissues and organs. BMP-7, also known as osteogenic protein-1 or OP-1, is a potent bone inducing agent, which in the presence of appropriate osteoconductive carrier (e.g. collagen sponge or synthetic hydroxyapatite) can be used in the treatment of bone defects. A bone-graft substitute, called OP-1TM implant, made of recombinant human BMP-7 associated with bovine bone-derived collagen, has recently been approved by the FDA as a device for treating critical-size bone fractures. The potential use of BMP-7 in dental reconstructive surgeries is currently under investigation. Recombinant human BMP-7 is a homodimeric glycoprotein consisting of two 117 amino acid subunits, which correspond to amino acid residues 315 to 431 of the full-length BMP 7 precursor. Recombinant human BMP-7 has a calculated molecular weight of 26.4 kDa; however, due to glycosylation, the BMP-7 homodimer migrates at an apparent molecular weight of approx. 25-35 kDa by SDS-PAGE analysis under non-reducing conditions.

Human BMP-7 Recombinant Protein

100-328S 2 µg
EUR 92.4
Description: TGF-β family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling and maintenance of a variety of other tissues and organs. BMP-7, also known as osteogenic protein-1 or OP-1, is a potent bone inducing agent, which in the presence of appropriate osteoconductive carrier (e.g. collagen sponge or synthetic hydroxyapatite) can be used in the treatment of bone defects. A bone-graft substitute, called OP-1TM implant, made of recombinant human BMP-7 associated with bovine bone-derived collagen, has recently been approved by the FDA as a device for treating critical-size bone fractures. The potential use of BMP-7 in dental reconstructive surgeries is currently under investigation. Recombinant human BMP-7 is a homodimeric glycoprotein consisting of two 117 amino acid subunits, which correspond to amino acid residues 315 to 431 of the full-length BMP 7 precursor. Recombinant human BMP-7 has a calculated molecular weight of 26.4 kDa; however, due to glycosylation, the BMP-7 homodimer migrates at an apparent molecular weight of approx. 25-35 kDa by SDS-PAGE analysis under non-reducing conditions.

Recombinant Human BMP-7 Protein

RP02513 20μg
EUR 520

BMP-7 Rabbit Polyclonal Antibody

ES1779-100ul 100ul
EUR 124
Description: A Rabbit Polyclonal antibody against BMP-7 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

BMP-7 Rabbit Polyclonal Antibody

ES1779-50ul 50ul
EUR 74
Description: A Rabbit Polyclonal antibody against BMP-7 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

BMP-7 Polyclonal Conjugated Antibody

C40651 100ul
EUR 476.4

BMP-7, Bone Morphogenetic Protein-7, human

RC219-18 2ug
EUR 125.26

Bone Morphogenetic Protein 7 (BMP-7) Antibody

abx411168-1ml 1 ml
EUR 610.8

Bone Morphogenetic Protein 7 (BMP-7) Antibody

abx412613-50ug 50 ug
EUR 610.8

Bone Morphogenetic Protein 7 (BMP-7) Antibody

abx411168-100g 100 µg
EUR 425

Bone Morphogenetic Protein 7 (BMP-7) Antibody

abx412613-1ml 1 ml
EUR 425

BMP-12/GDF-7, human recombinant

4572-100 each
EUR 738

BMP-12/GDF-7, human recombinant

4572-1000 each
EUR 5064

BMP-12/GDF-7, human recombinant

4572-20 each
EUR 333.6

Recombinant Human GDF-7/BMP-12

HEOPP-0707 10ug Ask for price

Recombinant Murine GDF-7/BMP-12

MEOPP-0705 10ug Ask for price

OPPA00541-2UG - BMP 7 Protein

OPPA00541-2UG 2ug
EUR 70

OPPA00596-2UG - BMP 7 Protein

OPPA00596-2UG 2ug
EUR 70

OPPA02098-10UG - BMP 7 Protein

OPPA02098-10UG 10ug
EUR 70

Rat BMP-7 PicoKine ELISA Kit

EK1444 96 wells
EUR 510
Description: For quantitative detection of rat BMP-7 in bone tissue, cell culture supernates, serum and plasma((heparin, EDTA).

Mouse BMP-7 PicoKine ELISA Kit

EK1443 96 wells
EUR 510
Description: For quantitative detection of mouse BMP-7 in bone tissue, cell culture supernates, serum and plasma((heparin, EDTA).

BMP-7 ELISA Kit (Human) (OKBB00356)

OKBB00356 96 Tests
EUR 652.8
Description: Description of target: Bone morphogenetic protein 7 or BMP7 (also known as osteogenic protein-1 or OP-1) is a protein that in humans is encoded by the BMP7 gene.The protein encoded by this gene is a member of the TGF-β superfamily. Like other members of the bone morphogenetic protein family of proteins, it plays a key role in the transformation of mesenchymal cells into bone and cartilage. It is inhibited by noggin and a similar protein, chordin, which are expressed in the Spemann-Mangold Organizer. BMP7 may be involved in bone homeostasis. It is expressed in the brain, kidneys and bladder.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 10 pg/ml

Genorise® Recombinant sheep BMP-7

GR104098 5 µg
EUR 285

Mouse Monoclonal anti-Human BMP-7

hAP-0119 100ug
EUR 250

Mouse Monoclonal anti-Human BMP-7

hAP-0119A 100ug
EUR 250

Sheep Polyclonal anti-Human BMP-7

hAP-5669 50ug
EUR 400

Genorise® Recombinant equine BMP-7

GR104023 5 µg
EUR 285

Genorise® Recombinant bovine BMP-7

GR104073 5 µg
EUR 285

Genorise® Recombinant canine BMP-7

GR104123 5 µg
EUR 285

Human BMP-7 Antibody (Biotin Conjugate)

32701-05121 150 ug
EUR 315

Genorise® Recombinant porcine BMP-7

GR104048 5 µg
EUR 285

Genorise® Recombinant chicken BMP-7

GR104148 5 µg
EUR 285

Human BMP-7 Recombinant Protein Lyophilized

IHUBMP7RLY2UG each
EUR 317
Description: Human BMP-7 Recombinant Protein Lyophilized

BMP-22

574213 1.0mg
EUR 270

BMP-10

RA30003 50 ug
EUR 726

BMP-22

T36138-10mg 10mg Ask for price
Description: BMP-22

BMP-22

T36138-1g 1g Ask for price
Description: BMP-22

BMP-22

T36138-1mg 1mg Ask for price
Description: BMP-22

BMP-22

T36138-50mg 50mg Ask for price
Description: BMP-22

BMP-22

T36138-5mg 5mg Ask for price
Description: BMP-22

BMP-2

E21-012 10ug
EUR 225
Description: Recombinant Human Bone Morphogenetic Protein 2 is produced by our E.coli expression system and the target gene encoding Gln283-Arg396 is expressed.

BMP-2

ant-183 100µg
EUR 155
Description: Mouse Anti Human Bone Morphogenetic protein-2

BMP-5

GT15054 100 ug
EUR 631.2

BMP-8

GT15161 100 ug
EUR 631.2

BMP-6

GT15167 100 ug
EUR 631.2

BMP-2

GWB-CC86ED 0.01 mg Ask for price

BMP-2

PR15013 10 ug
EUR 764.4

BMP-4

PR15015 10 ug
EUR 741.6

BMP-2

PR27023 2 ug
EUR 229.2

BMP-4

PR27024 2 ug
EUR 229.2

BMP-3

MO15038 500 ug
EUR 615.6

BMP-4

MO15134 100 ug
EUR 590.4

BMP-4

RA30035 50 ug
EUR 741.6

BMP-2

PR27023-B each
EUR 184.5

BMP-4

PR27024-B each
EUR 184.5

BMP-2/ Rat BMP- 2 ELISA Kit

ELA-E0013r 96 Tests
EUR 1063.2

BMP-4/ Rat BMP- 4 ELISA Kit

ELA-E0014r 96 Tests
EUR 1063.2

BMP-6/ Rat BMP- 6 ELISA Kit

ELA-E0646r 96 Tests
EUR 1063.2

OKAG00199-96W - BMP-7 ELISA Kit (Human)

OKAG00199-96W 1plate:12x8-WellMicrostrips
EUR 475

OKBB00356-96W - BMP-7 ELISA Kit (Human)

OKBB00356-96W 96Tests
EUR 431

OKRC00206-96W - BMP-7 ELISA Kit (Human)

OKRC00206-96W 96Wells
EUR 525

OKRC01103-96W - BMP-7 ELISA Kit (Mouse)

OKRC01103-96W 96Wells
EUR 525

Rat Bone Morphogenetic Protein 7 (BMP-7) CLIA Kit

abx195273-96tests 96 tests
EUR 990

Rat BMP-7 -Bone Morphogenetic Protein 7- CLIA Kit

E-CL-R0085-24Tests 24 Tests
EUR 180
Description: Sandwich

Rat BMP-7 -Bone Morphogenetic Protein 7- CLIA Kit

E-CL-R0085-48Tests 48 Tests
EUR 546
Description: Sandwich

Rat BMP-7 -Bone Morphogenetic Protein 7- CLIA Kit

E-CL-R0085-96Tests 96 Tests
EUR 682
Description: Sandwich

Rat BMP-7 -Bone Morphogenetic Protein 7- CLIA Kit

E-CL-R0085-96Tests10 96 Tests *10
EUR 6820
Description: Sandwich

Rat BMP-7 -Bone Morphogenetic Protein 7- CLIA Kit

E-CL-R0085-96Tests5 96 Tests *5
EUR 3410
Description: Sandwich

Rat BMP-7(Bone Morphogenetic Protein 7) ELISA Kit

EKF58152-48T 48T
EUR 396.9

Rat BMP-7(Bone Morphogenetic Protein 7) ELISA Kit

EKF58152-5x96T 5x96T
EUR 2693.25

Nine hundred and fifty-four participants (average age 55 years, 52% men) have information available in pulse oximetry and cardiometabolic risk markers. average oxyhemoglobin saturation was 90% (interquartile range 88% -92%) and 43 (4.5%) had excessive erythrocytosis. older age, decreased lung function height-adjustable, and a higher body mass index (BMI) is associated with having ≤85% oxyhemoglobin saturation.